91ÌÒÉ«

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open 91ÌÒÉ«

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91ÌÒÉ« Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91ÌÒÉ« Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Association between catechol-O-methyltransferase (COMT) Val/Met genotype and smoking cessation treatment with nicotine: A meta-analysis

3rd International Conference on Clinical Pharmacy

Choi Hye Duck1 and Shin Wan Gyoon2

1Yeungnam University, Republic of Korea 2Seoul National University, Republic of Korea

Posters-Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
COMT is one of the major degradative pathways of dopamine and COMT Val/Met polymorphisms are associated with the enzyme activity, which is related to dopamine involvement in the nicotine addiction process. However, the reported results of several genetic studies are not consistent. We reviewed the smoking cessation outcomes among previously reported studies by comparing COMT polymorphism. A total of five studies were assessed in the present meta-analysis and the Met/Met, Val/Met or Val/Val genotype were compared with respect to smoking cessation outcomes. As the results, any significant association between COMT polymorphism and smoking cessation were not observed. In the subgroup analysis, three studies were assessed for the association between the COMT polymorphism and smoking-cessation treatment with nicotine by comparing two groups (Met/Met vs. Val/ Met plus Val/Val). A significant association between COMT polymorphism and smoking cessation was observed (odd ratio=1.871 and 95% confidence interval 1.382�2.534). In conclusion, the COMT polymorphisms are associated with the outcomes following smoking cessation treatment with nicotine.
Biography

Email: chd80@hotmail.com

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top